Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Pavlides M, Mózes FE, Akhtar S, Wonders K, Cobbold J, Tunnicliffe EM, Allison M, Godfrey EM, Aithal GP, Francis S, Romero-Gomez M, Castell J, Fernandez-Lizaranzu I, Aller R, González RS, Agustin S, Pericàs JM, Boursier J, Aube C, Ratziu V, Wagner M, Petta S, Antonucci M, Bugianesi E, Faletti R, Miele L, Geier A, Schattenberg JM, Tilman E, Ekstedt M, Lundberg P, Berzigotti A, Huber AT, Papatheodoridis G, Yki-Järvinen H, Porthan K, Schneider MJ, Hockings P, Shumbayawonda E, Banerjee R, Pepin K, Kalutkiewicz M, Ehman RL, Trylesinksi A, Coxson HO; LITMUS Consortium Investigators; Martic M, Yunis C, Tuthill T, Bossuyt PM, Anstee QM, Neubauer S, Harrison S. Pavlides M, et al. Contemp Clin Trials. 2023 Nov;134:107352. doi: 10.1016/j.cct.2023.107352. Epub 2023 Oct 4. Contemp Clin Trials. 2023. PMID: 37802221 Free article.
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Lee J, Westphal M, Vali Y, Boursier J, Petta S, Ostroff R, Alexander L, Chen Y, Fournier C, Geier A, Francque S, Wonders K, Tiniakos D, Bedossa P, Allison M, Papatheodoridis G, Cortez-Pinto H, Pais R, Dufour JF, Leeming DJ, Harrison S, Cobbold J, Holleboom AG, Yki-Järvinen H, Crespo J, Ekstedt M, Aithal GP, Bugianesi E, Romero-Gomez M, Torstenson R, Karsdal M, Yunis C, Schattenberg JM, Schuppan D, Ratziu V, Brass C, Duffin K, Zwinderman K, Pavlides M, Anstee QM, Bossuyt PM; LITMUS investigators. Lee J, et al. Hepatology. 2023 Jul 1;78(1):258-271. doi: 10.1097/HEP.0000000000000364. Epub 2023 Mar 31. Hepatology. 2023. PMID: 36994719 Free article.
acFibroMASH index for the diagnosis of fibrotic MASH and prediction of liver-related events: An international multicenter study.
Feng G, Mózes FE, Ji D, Treeprasertsuk S, Okanoue T, Shima T, Liang H, Tsochatzis E, Chen J, Schattenberg JM, Labenz C, Mahadeva S, Chan WK, Chi X, Delamarre A, de Lédinghen V, Petta S, Bugianesi E, Hagström H, Boursier J, Calleja JL, Boon-Bee Goh G, Gallego-Durán R, Sanyal AJ, Fan JG, Castéra L, Lai M, Harrison SA, Romero-Gomez M, Kim SU, Zhu Y, Ooi G, Shi J, Yoneda M, Nakajima A, Zhang J, Lupsor-Platon M, Zhong B, Cobbold JFL, Ye CY, Eddowes PJ, Newsome P, Li J, George J, He F, Song MJ, Tang H, Fan Y, Jia J, Xu L, Lin S, Li Y, Lu Z, Nan Y, Niu J, Yan X, Zhou Y, Liu C, Deng H, Ye Q, Zeng QL, Li L, Wang J, Yang S, Lin H, Lee HW, Cheuk-Fung Yip T, Fournier-Poizat C, Lai-Hung Wong G, Pennisi G, Armandi A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Jun Teh KK, Romero CL, Asgharpour A, Mahgoub S, Sau-Wai Chan M, Canivet CM, Ji F, Xin Y, Chai J, Dong Z, Targher G, Byrne CD, He N, Mi M, Ye F, Wai-Sun Wong V, Pavlides M, Zheng MH. Feng G, et al. Among authors: harrison sa. Clin Gastroenterol Hepatol. 2024 Oct 1:S1542-3565(24)00863-2. doi: 10.1016/j.cgh.2024.07.045. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39362618
Letter to the Editor: Serum identification of At-Risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Noureddin M, Truong E, Mayo R, Martínez-Arranz I, Mincholé I, Banales JM, Arrese M, Cusi K, Arias-Loste MT, Bruha R, Romero-Gómez M, Iruzubieta P, Aller R, Ampuero J, Calleja JL, Ibañez-Samaniego L, Aspichueta P, Marín-Duce A, Kushner T, Ortiz P, Harrison SA, Anstee QM, Crespo J, Mato JM, Sanyal AJ. Noureddin M, et al. Among authors: harrison sa. Hepatology. 2024 Sep 26. doi: 10.1097/HEP.0000000000001061. Online ahead of print. Hepatology. 2024. PMID: 39325967 No abstract available.
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients with MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis.
Noureddin M, Charlton MR, Harrison SA, Bansal MB, Alkhouri N, Loomba R, Sanyal AJ, Rinella ME. Noureddin M, et al. Among authors: harrison sa. Clin Gastroenterol Hepatol. 2024 Jul 20:S1542-3565(24)00667-0. doi: 10.1016/j.cgh.2024.07.003. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39038768 Free article. Review.
383 results